https://www.selleckchem.com/pr....oducts/Raltitrexed.h
g LUAD patients and DMSO-treated A549 cells. And the different expression of neurotensin, neuronatin, trefoil factor family2, regenerating family member 4, miR-377-5p, miR-34a were verified with the same tendency in our own samples. Non-smoking LUAD patients, compared to smokers, have different characteristics in terms of somatic mutation, gene, and miRNA expression and the microenvironment, indicating a diverse mechanism of oncogenesis. Non-smoking LUAD patients, compared to smokers, have different characteristics in terms of somat
Beğen
Yorum Yap
Paylaş
